Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma (Cancer Chemotherapy and Pharmacology, (2017), 80, 4, (715-721), 10.1007/s00280-017-3405-7)

Michael A. Badruddoja, Marjorie Pazzi, Abhay Sanan, Kurt Schroeder, Kevin Kuzma, Thomas Norton, Thomas Scully, Daruka Mahadevan, Michael Malek Ahmadi

Producción científica: Comment/debate › revisión exhaustiva

1 Cita (Scopus)

Huella

Profundice en los temas de investigación de 'Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma (Cancer Chemotherapy and Pharmacology, (2017), 80, 4, (715-721), 10.1007/s00280-017-3405-7)'. En conjunto forman una huella única.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience